1225-56-5CNCCC=C1c2ccccc2COc2ccccc21HVKCEFHNSNZIHO-UHFFFAOYSA-Nactive metabolite if doxepin; RN given refers to cpd without isomeric designation
1225-56-5DTXSID9075406Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.
UsesDesmethyldoxepin solution may be used as an internal standard in the high performance liquid chromatographic (HPLC) determination of bupivacaine in samples of human serum.
General DescriptionDesmethyldoxpein is the primary urinary metabolite of doxepin, a tricyclic antidepressant used for the treatment of sleep maintenance and sold under trade names such as Silenor and Aponal. This analytical reference standard is suited for use in LC/MS or GC/MS methods for urine drug testing, clinical toxicology, and forensic analysis applications.
Loading…
DefinitionChEBI: (E)-desmethyldoxepin is the (E)-isomer of desmethyldoxepin.